Short androgen suppression and radiation dose escalation in prostate cancer: 12-year results of EORTC trial 22991 in patients with localized intermediate-risk …
M Bolla, A Neven, P Maingon, C Carrie… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE The European Organisation for Research and Treatment of Cancer (EORTC) trial
22991 (NCT00021450) showed that 6 months of concomitant and adjuvant androgen …
22991 (NCT00021450) showed that 6 months of concomitant and adjuvant androgen …
RETRACTED: Recommandations françaises du Comité de Cancérologie de l'AFU–Actualisation 2018–2020: cancer de la prostate
F Rozet, C Hennequin, JB Beauval, P Beuzeboc… - Progrès en urologie, 2018 - Elsevier
Author links open overlay panel F. Rozet ab, C. Hennequin ac, J.-B. Beauval ad, P.
Beuzeboc ae, L. Cormier af, G. Fromont-Hankard ag, P. Mongiat-Artus ah, G. Ploussard ai …
Beuzeboc ae, L. Cormier af, G. Fromont-Hankard ag, P. Mongiat-Artus ah, G. Ploussard ai …
[HTML][HTML] Benefits of adopting hypofractionated radiotherapy as a standard of care in low-and middle-income countries
METHODS An exhaustive review of available literature was performed using the PubMed
database. Publications pertaining to hypofractionated radiotherapy and cost-effectiveness …
database. Publications pertaining to hypofractionated radiotherapy and cost-effectiveness …
Diminishing returns from ultrahypofractionated radiation therapy for prostate cancer
IR Vogelius, SM Bentzen - … Journal of Radiation Oncology* Biology* Physics, 2020 - Elsevier
Purpose More than a decade of randomized controlled trials in prostate cancer has
established a positive radiation dose response at moderate doses and a consistently low α/β …
established a positive radiation dose response at moderate doses and a consistently low α/β …
Comparison of response to definitive radiotherapy for localized prostate cancer in Black and White men: a meta-analysis
Importance Black men have a 2-fold increased risk of dying from prostate cancer compared
with White men. However, race-specific differences in response to initial treatment remain …
with White men. However, race-specific differences in response to initial treatment remain …
[HTML][HTML] Gating has a negligible impact on dose delivered in MRI-guided online adaptive radiotherapy of prostate cancer
Background and purpose MR-guided radiotherapy (MRgRT) allows real-time beam-gating
to compensate for intra-fractional target position variations. This study investigates the …
to compensate for intra-fractional target position variations. This study investigates the …
[HTML][HTML] Intensity-modulated radiotherapy for prostate cancer
BW Fischer-Valuck, YJ Rao… - … andrology and urology, 2018 - ncbi.nlm.nih.gov
Radiation therapy (RT) is a curative treatment modality for localized prostate cancer. Over
the past two decades, advances in technology and imaging have considerably changed RT …
the past two decades, advances in technology and imaging have considerably changed RT …
Shorter radiation regimens and treatment noncompletion among patients with breast and prostate cancer in the United States: An analysis of racial disparities in …
PURPOSE: Compared with conventional external-beam radiation therapy (cEBRT) for
patients with breast cancer (BC) and prostate cancer (PC), shorter radiation regimens may …
patients with breast cancer (BC) and prostate cancer (PC), shorter radiation regimens may …
Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis …
Introduction To characterize the efficacy (5-year disease-free survival [DFS]) and safety
(incidence of grade 2+ late gastrointestinal or genitourinary toxicity) of ultrahypofractionated …
(incidence of grade 2+ late gastrointestinal or genitourinary toxicity) of ultrahypofractionated …
[HTML][HTML] The role of hypofractionated radiotherapy in prostate cancer
LC Benjamin, AC Tree, DP Dearnaley - Current oncology reports, 2017 - Springer
Abstract Purpose of Review It is now accepted that prostate cancer has a low alpha/beta
ratio, establishing a strong basis for hypofractionation of prostate radiotherapy. This review …
ratio, establishing a strong basis for hypofractionation of prostate radiotherapy. This review …